52 Week low, Analyst Buy recommendations 6 Buy, 3 Hold, 0 Sell

NASDAQ:SMMT   Summit Therapeutics Inc.
This may be catching a falling knife, but I found SMMT on my scanner after it was down 50% in a day
If you look at all the analyst ratings on this stock there's no reason it should be down where it is right now.
It's down to $2.44 right now at it's 52 week low when just weeks ago it was worth $12 a share.
This is a bargain, it's fallen hard before but there's good reason for it to return to where it was.

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.